| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 4,867 | 8,845 | ||
| Prepaid expenses | 373 | 1,333 | ||
| Total current assets | 5,240 | 10,178 | ||
| Total property and equipment at cost | 1,290 | - | ||
| Less accumulated depreciation | 382 | - | ||
| Property and equipment, net | 908 | 967 | ||
| Operating lease right-of-use asset, net | 2,548 | 2,714 | ||
| Other assets | 48 | 48 | ||
| Total assets | 8,744 | 13,907 | ||
| Accounts payable and accrued expenses | 1,069 | 1,801 | ||
| Operating lease liability, short-term | 643 | 627 | ||
| Sepa put option liability | 437 | 470 | ||
| Short-term convertible debt | 4,573 | 8,066 | ||
| Total current liabilities | 6,722 | 10,964 | ||
| Preferred stock, value-Series CPreferred Stock | - | 0 | ||
| Operating lease liability, long-term | 1,897 | 2,083 | ||
| Preferred stock, value | - | 0 | ||
| Total liabilities | 8,619 | 13,047 | ||
| Additional paid-in capital | 51,045 | 46,002 | ||
| Accumulated deficit | -50,920 | -45,142 | ||
| Total stockholders equity | 125 | 860 | ||
| Total liabilities and stockholders equity | 8,744 | 13,907 | ||
FibroBiologics, Inc. (FBLG)
FibroBiologics, Inc. (FBLG)